Annual report [Section 13 and 15(d), not S-K Item 405]

Share-Based Compensation (Tables)

v3.25.3
Share-Based Compensation (Tables)
 12 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense

The Company recorded share-based compensation expense associated with the RSUs and RSAs in its accompanying consolidated statements of operations as follows:

 

         
    Years ended September 30,  
    2025     2024  
Research and development   $ 66,896     $ 109,356  
General and administrative     132,699       121,834  
Share-based compensation   $ 199,595     $ 231,190  
Schedule of Restricted Stock Units Activity

The following table summarizes RSU activity under the Plan:

 

          Weighted  
          Average Grant  
    RSU     Date Fair Value  
Unvested balance at October 1, 2023     288     $ 174.26  
Granted     9,175     $ 14.08  
Vested     (288 )   $ 174.26  
Forfeited     —     $ —  
Unvested balance at September 30, 2024     9,175     $ 14.08  
Granted     120,000     $ 4.64  
Vested     (9,175 )   $ 14.08  
Forfeited     —     $ —  
Unvested balance at September 30, 2025     120,000     $ 4.64  
Schedule of Restricted Stock Awards Activity

The following table summarizes RSA activity under the Plan:

 

          Weighted  
          Average Grant  
    RSA     Date Fair Value  
Unvested balance at October 1, 2023     688     $ 226.16  
Granted     7,977     $ 14.08  
Vested     (688 )   $ 226.16  
Unvested balance at September 30, 2024     7,977     $ 14.08  
Granted     —     $ —  
Vested     (7,977 )   $ 14.08  
Unvested balance at September 30, 2025     —     $ —